EP0948346A4 - USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS - Google Patents

USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS

Info

Publication number
EP0948346A4
EP0948346A4 EP97947488A EP97947488A EP0948346A4 EP 0948346 A4 EP0948346 A4 EP 0948346A4 EP 97947488 A EP97947488 A EP 97947488A EP 97947488 A EP97947488 A EP 97947488A EP 0948346 A4 EP0948346 A4 EP 0948346A4
Authority
EP
European Patent Office
Prior art keywords
mii
imi
cardiovascular agents
conotoxin peptides
conotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97947488A
Other languages
German (de)
French (fr)
Other versions
EP0948346A1 (en
Inventor
J Michael Mcintosh
Baldomero M Olivera
Doju Yoshikami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Original Assignee
University of Utah Research Foundation UURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation UURF filed Critical University of Utah Research Foundation UURF
Publication of EP0948346A1 publication Critical patent/EP0948346A1/en
Publication of EP0948346A4 publication Critical patent/EP0948346A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
EP97947488A 1996-11-18 1997-11-17 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS Withdrawn EP0948346A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3114196P 1996-11-18 1996-11-18
US31141P 1996-11-18
PCT/US1997/020669 WO1998022126A1 (en) 1996-11-18 1997-11-17 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS

Publications (2)

Publication Number Publication Date
EP0948346A1 EP0948346A1 (en) 1999-10-13
EP0948346A4 true EP0948346A4 (en) 2004-05-12

Family

ID=21857857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97947488A Withdrawn EP0948346A4 (en) 1996-11-18 1997-11-17 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS

Country Status (5)

Country Link
EP (1) EP0948346A4 (en)
JP (1) JP2001505878A (en)
AU (1) AU735724B2 (en)
CA (1) CA2271769A1 (en)
WO (1) WO1998022126A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308115A1 (en) * 1997-10-24 1999-05-06 University Of Utah Research Foundation Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
US6797808B1 (en) * 1999-01-29 2004-09-28 University Of Utah Research Foundation α-conotoxin peptides
WO2000044776A1 (en) * 1999-01-29 2000-08-03 University Of Utah Research Foundation Alpha-conotoxin peptides
US7851444B2 (en) 2002-12-02 2010-12-14 Xenome Ltd. χ-conotoxin peptides (-1)
EP1578787B1 (en) 2002-12-02 2012-11-14 Xenome Ltd Novel chi-conotoxin peptides (-ii)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2262886A (en) * 1991-12-17 1993-07-07 Lilly Industries Ltd Calcium channel blocking drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189020A (en) * 1989-11-22 1993-02-23 Neurex Corporation Method of reducing neuronal damage using omega conotoxin peptides
US5514774A (en) * 1993-06-29 1996-05-07 University Of Utah Research Foundation Conotoxin peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2262886A (en) * 1991-12-17 1993-07-07 Lilly Industries Ltd Calcium channel blocking drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9822126A1 *

Also Published As

Publication number Publication date
EP0948346A1 (en) 1999-10-13
WO1998022126A1 (en) 1998-05-28
JP2001505878A (en) 2001-05-08
CA2271769A1 (en) 1998-05-28
AU735724B2 (en) 2001-07-12
AU5255598A (en) 1998-06-10

Similar Documents

Publication Publication Date Title
EP0880356A4 (en) Antimicrobial peptides and methods of use
ZA9710569B (en) Novel benzamides and their application
PL327658A1 (en) Disinfecting compositions and methods of disinfecting surfaces
SG55368A1 (en) Abrasive composition and use of the same
IL126758A0 (en) Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
GB9617021D0 (en) Novel peptides for treatment of inflammation and shock
EP0964032A4 (en) New composition and treating agent
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
GB9615089D0 (en) Esters and compositions comprising them
EP0960191A4 (en) Compositions and methods for use of defensin
ZA985096B (en) Composition compound and use
GB9525812D0 (en) Composition and use
GB9717598D0 (en) Novel composition and use
IL125734A (en) Antipathogenic peptides and compositions comprising them
PL327945A1 (en) Disinfecting compositions and methods of disinfecting surfaces
PL307781A1 (en) Cosmeticf detergent composition and application thereof
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
EP0948346A4 (en) USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
HUP9904332A3 (en) Compositions and articles of manufacture
HUP9800146A3 (en) Thalidomide-derivatives and use of them
HUP0400922A3 (en) Detergent compositions and their use
GB9608505D0 (en) Compositions processes and uses
PL328334A1 (en) Preparation and application thereof
GB9718636D0 (en) Novel composition and use
GB2299828B (en) Construction and repair of timber components

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990517

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20040325

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040612